As of January 23, 2025, Tempest Therapeutics (TPST) has a market cap of $38.532 million USD. According to our data, Tempest Therapeutics is ranked No.8294 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $38.53 M |
5.74%
|
Dec 31, 2024 | $36.44 M |
-81.02%
|
Dec 29, 2023 | $0.19 B |
282.61%
|
Dec 30, 2022 | $50.19 M |
-78.22%
|
Dec 31, 2021 | $0.23 B |
-83.55%
|
Dec 31, 2020 | $1.40 B |
-68.25%
|
Dec 31, 2019 | $4.41 B |
-15.22%
|
Dec 31, 2018 | $5.20 B |
-62.14%
|
Dec 29, 2017 | $13.75 B |
-8.50%
|
Dec 30, 2016 | $15.02 B |
-84.34%
|
Dec 31, 2015 | $95.94 B |
-77.91%
|
Dec 31, 2014 | $434.22 B |
383.81%
|
Dec 31, 2013 | $89.75 B |
9.20%
|
Dec 31, 2012 | $82.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
Zai Lab
ZLAB
|
$3.03 B |
0.125 B
|
China
|
Market Cap | = | TPST Stock Price | * | TPST Shares Outstanding |
= | $0.88 | * | 43.64 M | |
= | $38.53 M |